30 July 2024
Hogan Lovells advises CatalYm on a USD 150 million venture capital funding round
Advising firms
Deal team
2 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Thiemo Woertge Lead | Hogan Lovells Cadwalader | Counsel | Not stated | Munich |
| Dr Nikolas Zirngibl Lead | Hogan Lovells Cadwalader | Partner | Not stated | Not stated |
Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 150m (USD 150 million)
- What the figure measures
- Fund size
- Client
- CatalYm GmbHIssuer
- Counterparties
- Canaan Partners (Investor)
Bioqube Ventures (Investor)
Forbion's Growth Opportunities Fund (Investor)
Omega Funds (Investor)
Gilde Healthcare (Investor)
Jeito Capital (Investor)
Brandon Capital Partners (Investor)
Novartis Venture Fund (Investor)
Vesalius Biocapital (Investor)